Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
Osteoporosis
•
Ehlers Danlos Syndrome
•
Endocrinology
Would you start anabolic bone therapy in an patient with Ehlers Danlos, low bone density and no fracture history who is found to have "spongy soft bone" during spine surgery?
In this case, spine surgeon is recommending anabolic bone therapy post-op.
Related Questions
Would atypical fractures of the hip in a parent (treated with bisphosphonate) be considered when calculating the FRAX score for a patient with osteopenia?
Is history of radiation an absolute contraindication to using parathyroid hormone (PTH) analogues?
How do you reduce the risk of contralateral fracture in a patient with atypical femur fracture from prolonged bisphosphonate use?
After completing 12 months romosozumab, what is the next best treatment option for patients with severe osteoporosis, high risk for fracture, and normal kidney function?
Would you use romosozumab in a patient with a cardiovascular event more than 2 years prior?
How do you reconcile differences in Lunar and Hologic T-scores?
Can anabolic agents be used in a patient with history of radioactive iodine treatment for hyperthyroidism?
In a patient with history of atypical femoral fracture while on denosumab how do you sequence further treatment options?
What is your approach to managing osteoporosis in patients with end stage kidney disease?
How would you approach treatment of glucocorticoid induced osteoporosis in a patient 10 years post renal transplant, egfr > or =35, on chronic prednisone therapy who has completed 10 years of bisphosphonate therapy and whose DEXA continues to be T-score <~2.5?